Christer Halldin Selected Research

Christer Halldin Research Topics

Disease

27	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2009
23	Schizophrenia (Dementia Praecox) 01/2022 - 01/2002
18	Parkinson Disease (Parkinson's Disease) 12/2020 - 10/2004
16	Mental Disorders (Mental Disorder) 01/2018 - 03/2002
13	Neuroinflammatory Diseases 01/2021 - 01/2009
10	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 11/2011
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2008
9	Huntington Disease (Huntington's Disease) 01/2021 - 10/2011
4	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2010
4	Stroke (Strokes) 04/2016 - 11/2002
4	Amyloid Plaque 09/2015 - 08/2010
3	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2019
3	Disease Progression 01/2020 - 01/2012
3	Gliosis 03/2017 - 01/2011
3	Infarction (Infarctions) 04/2016 - 01/2012
2	Neoplasms (Cancer) 12/2021 - 01/2020
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2008
2	Dyskinesias (Dyskinesia) 01/2019 - 10/2018
2	Hypersensitivity (Allergy) 01/2018 - 02/2011
2	Cognitive Dysfunction 01/2018 - 01/2016
2	Ischemic Stroke 04/2016 - 09/2012
2	Obesity 02/2016 - 03/2014
2	Mood Disorders (Mood Disorder) 02/2015 - 10/2013
2	Anxiety Disorders (Anxiety Disorder) 02/2014 - 11/2013
2	Nervous System Diseases (Neurological Disorders) 06/2013 - 01/2010
2	Multiple Sclerosis 04/2013 - 01/2008
2	Juvenile Myoclonic Epilepsy 02/2012 - 06/2005
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2006 - 02/2005
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2002 - 08/2002
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2021
1	Autistic Disorder (Autism) 01/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2009
15	Pharmaceutical PreparationsIBA 01/2020 - 01/2002
14	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 05/2002
14	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 03/2002
14	Biomarkers (Surrogate Marker)IBA 08/2020 - 04/2008
11	Amyloid (Amyloid Fibrils)IBA 07/2019 - 11/2009
9	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2020 - 09/2000
9	LigandsIBA 01/2020 - 01/2009
7	Dopamine Receptors (Dopamine Receptor)IBA 01/2020 - 05/2002
7	EnzymesIBA 01/2020 - 01/2011
6	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 06/2016
6	vinpocetineIBA 09/2012 - 08/2002
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 05/2002
5	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2021 - 01/2003
5	5-HT1B Serotonin ReceptorIBA 01/2019 - 07/2008
5	RacloprideIBA 05/2012 - 02/2005
4	Monoamine Oxidase (MAO)IBA 12/2020 - 01/2011
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2019 - 09/2006
4	Amyloid beta-PeptidesIBA 01/2018 - 10/2010
3	5-HT1A Serotonin ReceptorIBA 01/2022 - 06/2005
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2021 - 01/2009
3	Neurotransmitter Agents (Neurotransmitter)IBA 03/2017 - 12/2014
3	2- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- olIBA 09/2015 - 11/2009
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 03/2014 - 02/2012
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2013 - 06/2010
3	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 04/2013 - 01/2008
3	Peptides (Polypeptides)IBA 04/2012 - 01/2012
3	FLB 457IBA 12/2006 - 01/2002
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2006 - 01/2002
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 11/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 10/2016
2	polyglutamineIBA 01/2021 - 01/2020
2	Metabotropic Glutamate 5 ReceptorIBA 01/2020 - 01/2018
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020 - 07/2019
2	Ketamine FDA LinkGeneric 01/2020 - 03/2015
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 10/2018
2	metabotropic glutamate receptor 4IBA 01/2019 - 10/2018
2	SCH 23390IBA 01/2019 - 05/2002
2	VortioxetineIBA 01/2019 - 10/2013
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 08/2008
2	Insulin (Novolin)FDA Link 12/2018 - 03/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 02/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017 - 09/2015
2	AZD3241IBA 09/2015 - 06/2015
2	Peroxidase (Myeloperoxidase)IBA 09/2015 - 06/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2015 - 12/2014
2	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2015 - 09/2006
2	Quetiapine Fumarate (Seroquel)FDA Link 11/2013 - 11/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2013 - 09/2012
2	N- (5- fluoro- 2- phenoxyphenyl)- N- (2- fluoroethyl- 5- methoxybenzyl)acetamideIBA 06/2013 - 04/2013
2	4- cyano- 1- (2- iodophenyl)- 5- (4- methoxyphenyl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamideIBA 04/2012 - 02/2012
2	N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA 02/2012 - 02/2005
2	Clozapine (Clozaril)FDA LinkGeneric 11/2011 - 03/2003
2	multidrug resistance-associated protein 1IBA 02/2011 - 06/2010
2	Biological ProductsIBA 03/2010 - 02/2008
1	Glycoproteins (Glycoprotein)IBA 12/2022
1	AZD1390IBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Flumazenil (Romazicon)FDA LinkGeneric 01/2021
1	pyrimidineIBA 01/2021
1	Fluorine-18IBA 12/2020
1	Carbon-11IBA 12/2020
1	osimertinibIBA 01/2020
1	fenobamIBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2017 - 01/2012
2	Aftercare (After-Treatment) 10/2021 - 09/2015
2	Oral Administration 03/2017 - 08/2002
1	Radiotherapy 12/2021